Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
63 hedge funds and large institutions have $858M invested in Repare Therapeutics in 2020 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 3 closing their positions.
800% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 3
62% more funds holding
Funds holding: 39 → 63 (+24)
18% more capital invested
Capital invested by funds: $729M → $858M (+$130M)
2.97% more ownership
Funds ownership: 64.97% → 67.93% (+3%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
8% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$19M |
| 2 |
BlackRock
New York
|
+$10.9M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.04M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$7.25M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$6.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$8.96M |
| 2 |
IC
Ikarian Capital
Dallas,
Texas
|
-$5.86M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3M |
| 4 |
Millennium Management
New York
|
-$2.83M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$2.77M |
RPTX Hedge Fund Activity: Q4 2020 in Review
63 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q4 2020, worth a combined $858M — up 18% from $729M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new RPTX positions and 3 closed out — a net gain of 24 holders — while 12 added to existing stakes and 13 trimmed.
The largest buyer was ARK Investment Management, opening a new position worth an estimated $19M. The largest seller was Logos Global Management, cutting an estimated $8.96M.
- 63 institutional investors held Repare Therapeutics (RPTX) as of Q4 2020, up from 39 in Q3 2020.
- Funds reported $858M of Repare Therapeutics stock for Q4 2020, up 18% quarter-over-quarter.
- 27 funds opened new Repare Therapeutics positions in Q4 2020 and 3 closed out, a net change of +24 holders.
- The largest Repare Therapeutics buyer in Q4 2020 was ARK Investment Management, an estimated $19M added.
- The largest Repare Therapeutics seller in Q4 2020 was Logos Global Management, an estimated $8.96M sold.
Based on aggregated 13F filings for Q4 2020.